# Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)

Study · id `cardio:ct-nct03948867` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03948867](<https://clinicaltrials.gov/study/NCT03948867>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03948867

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 202 participants.

## Technical summary

Registry record NCT03948867. Non-randomized; no masking; primary purpose treatment. Start 2019-04-24 (actual); primary completion 2022-09-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 202 participants (enrolled count; ClinicalTrials.gov record NCT03948867, source copy `cardio:ctgov-nct03948867-2026-10-19`, retrieved 2026-10-26)
- Started: 2019-04-24 (actual) (ClinicalTrials.gov record NCT03948867, source copy `cardio:ctgov-nct03948867-2026-10-19`, retrieved 2026-10-26)
- Primary completion: 2022-09-05 (actual) (ClinicalTrials.gov record NCT03948867, source copy `cardio:ctgov-nct03948867-2026-10-19`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT03948867, source copy `cardio:ctgov-nct03948867-2026-10-19`, retrieved 2026-10-26)
- Countries: United States; Tanzania (ClinicalTrials.gov record NCT03948867, source copy `cardio:ctgov-nct03948867-2026-10-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03948867-2026-10-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)
- Condition: Sickle Cell Anemia in Children
- Intervention (Drug): Hydroxyurea
- Intervention (Diagnostic test): Elevated Arm TCD Examination
- Intervention (Diagnostic test): Normal Arm TCD Examination
- Lead sponsor: Children's Hospital Medical Center, Cincinnati
- Lead sponsor class: OTHER
- Collaborator: Bugando Medical Centre
- Collaborator class: UNKNOWN
- Collaborator: The American Society of Hematology
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Children's Hospital Medical Center, Cincinnati (`cardio:org-children-s-hospital-medical-center-cincinnati`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial (`cardio:pubmed-36870358`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fcce1fbcf3741d2f629174fa3aceff5c293912f093c84f9b954da5238b389be4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
